Stay updated on Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new 'Revision: v3.3.3' label appears on the page, while the 'HHS Vulnerability Disclosure' and the 'Revision: v3.3.2' entries are removed from the footer.
    Difference
    0.2%
    Check dated 2025-12-22T21:48:24.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The latest record now shows Revision: v3.3.2 in the history, with v3.3.1 removed from the list. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T15:39:02.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces v3.2.0; no substantive changes to the study record content or data are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:43:52.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed the notice about government funding delays and potential information currency from the page header. The page now presents the standard study details without that disclaimer.
    Difference
    0.5%
    Check dated 2025-11-17T06:20:46.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    No significant content changes detected between the old and new versions; the updates appear to be minor UI/layout adjustments to the page header and navigation while study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:58:24.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    - Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T10:04:41.000Z thumbnail image

Stay in the know with updates to Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Efficacy in Stage II-III NSCLC Clinical Trial page.